Research and Development
BTG acquires promising oncology pipeline in Galil Medical takeover
May 9, 2016 Manufacturing and Production, Research and Development, Sales and Marketing $84 million, BTG, cryoablation, galil medical, oncology, takeover
Phase III trial meets primary endpoint for Allergan’s fibroid treatment
May 9, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Allergan, fibroid, phase 3, phase III, ulipristal, ulipristal acetate, uterine fibroid
Weekly Movers: Bind Therapeutics, Sarepta, Idexx…
May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Clovis cuts staff by 35% after FDA knock back on lung cancer drug
May 6, 2016 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Q1 results, clovis, failure, job cuts, job losses, rociletinib, workforce
Focus: Medivation tug-of-war rumbles on
May 6, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, Medivation, Pfizer, Sanofi, billion dollar, competition, oncology, pipeline, promising, takeover, tug of war
Pfizer teams up with Wave Life Sciences for metabolic disease research
May 6, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, metabolic disease, nucelic acid therapies, partnership, wave life sciences
Amgen looking to join the fray, mulling Medivation bid – Reports
May 5, 2016 Research and Development, Sales and Marketing Amgen, AstraZeneca, Deals, M&A, MA, Medivation, Pfizer, Sanofi
Valeant’s Bausch + Lomb teams up with IBM for cataract surgery app
May 5, 2016 Research and Development Bausch and Lomb, Valeant, app, cataract, cataract surgery, ibm, ipad, iphone, surgeons
Sanofi sends letter to Medivation board; claims shareholders want takeover
May 5, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Medivation, Sanofi, board, brandicourt, hostile, shareholders, takeover
Eisai says European Commission backs Halaven to treat of advanced Liposarcoma in Europe
May 5, 2016 Research and Development, Sales and Marketing EC, Eisai, US FDA, oncology, regulation, soft tissue sarcoma
One in three antibiotic prescriptions in US unnecessary, says CDC
May 5, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, antibiotic, prescribing, prescriptions, unnecessary
Bayer’s liver cancer drug meets primary endpoint in late stage trial
May 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Stivarga, late stage trial, liver cancer, phase III, regorafenib, trial
Biogen to spin off its haemophilia business
May 4, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Biogen, Business, alprolix, eloctate, haemophilia, hemophilia, spin off, spin-off
Nice extends price-negotiation talks for PTC’ muscle wasting drug
May 4, 2016 Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, NICE, PTC Therapeutics, Translarna, market access, regulation
Pfizer revenue jumps 20%; ups FY16 outlook
May 4, 2016 Research and Development, Sales and Marketing Pfizer, Q1, earnings, results, revenue, sales
